Garcia CE, Crespo RE, Guanche GH

Language: Spanish
References: 18
Page: 453-462
PDF size: 189.88 Kb.

ABSTRACT

Introduction: helicobacter pylori infection constitutes the chronic infection most widely spread amongst the human race.
Objective: to determine the clinical-epidemiological characteristics of Helicobacter pylori infection in patients who attended the Gastroenterology office.
Method: a descriptive observational study was performed with a universe of 240 patients with Helicobacter pylori determined by Ziehl Neelsen basic fuchsine staining, while the sample was confirmed by 204 patients tested positive to that test. The considered variables were age, sex, histological diagnosis, clinical symptoms, and clinical history following the specific treatment of Helicobacter pylori. Frequencies distribution was used as a statistical analysis technique.
Results: Helicobacter pylori infection, in the 85 % of the studies cases, with a predominance of the male sex, being chronic gastritis with 63,7% the gastric disorder more associated with the infection, while epigastric pain was the most frequent symptom and 44,6 % of the cases had a unsatisfactory evolution.
Conclusions: a high percentage of Helicobacter pylori infection was obtained.

REFERENCES

1. Malaty HM. Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 2007; 21 (2): 205-14.

2. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010; 362: 1597-604.

3. Piñol Jiménez F, Paniagua Estévez M, Gra Oramas B, Reyes de la Cruz M. Helicobacter pylori y lesiones endoscópicas e histológicas en mucosa gástrica de pacientes de 50 años y más. Rev cubana med [online]. 2008, vol.47, n.2 [citado 2013-01-26]

4. Boyanova L R K. Helicobacter pylori Sherris Medical Microbiology. McGraw-Hill. 2008; pp. 573 - 576.

5. Kusters JG, Van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection». Clin Microbiol Rev.2006; 19 (3): 449-90. 2006.

6. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008;134 (1): 306-23.

7. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010;362:1597e 604.

8. Cuba. MINSAP. Anuario estadístico Oficina Nacional de Estadísticas e Información, Republica de Cuba. La Habana: MINSAP; 2011

9. Selgrad M, Malfertheiner P. Treatment of Helicobacterpylori. Current Opinion in Gastroenterology 2011; 27 (6):565-570.

10. Gisbert JP. Helicobacter pylori-related diseases: dyspepsia. Gastroenterol Hepatol 2012;35 (Suppl 1):12-25.

11. Pajares G. Dispepsia funcional y Helicobacter pylori: ¿convivencia estable? Rev Esp Enferm Dig. 2008; 100(9):525-31.

12. Malfertheiner P, Megraud F.. Management of Helicobacter pylori infection the Maastricht IV/ Florence Consensus Report. gut.bmj.com on January 25, 2013

13. Sachs G, Scott DR, Wen Y. Gastric infection by Helicobacter pylori. Current Gastroenterology Reports 2011 13(6):540-546.

14. Suzuki H, Nishizawa T, Hibi T. Helicobacter pylori eradication therapy. Future Microbiol 2010;5(4):639-48.

15. Furuta T, Graham DY. Pharmacologic aspects of eradication therapy for Helicobacter pylori infection. Gastroenterology Clinics of North America 2010; 39 (3): 465-480.

16. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010; 59:1143-53.

17. Stenström B, Mendis A, Marshall B. Helicobacter pylori. The latest in diagnosis and treatment. Aust Fam Physician 2008; 37 (8): 608-12.

18. Selgrad M, Malfertheiner P. New strategies for HP eradication. Curr Opin Pharmacol 2008; 8 (5): 593-7.